ANGIOPOIETIN 2-BASED POLYPEPTIDE INHIBITORS AND METHODS OF USE THEREOF

Described herein is the generation of inhibitory polypeptides based on the Ang2- binding domain (Ang2-BD), but having greater affinity for Tie2 and/or integrin alpha v beta 3 (ανβ3) than the native Ang2-BD. Uses of the generated Ang2-BD variants as cancer and anti- angiogenesis therapeutics are also...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAPO, Niv, SHLAMKOVICH, Tomer
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PAPO, Niv
SHLAMKOVICH, Tomer
description Described herein is the generation of inhibitory polypeptides based on the Ang2- binding domain (Ang2-BD), but having greater affinity for Tie2 and/or integrin alpha v beta 3 (ανβ3) than the native Ang2-BD. Uses of the generated Ang2-BD variants as cancer and anti- angiogenesis therapeutics are also described. L'invention concerne la génération de polypeptides inhibiteurs basés sur le domaine de liaison à Ang2 (Ang2-BD), mais ayant une affinité plus importante pour Tie2 et/ou l'intégrine alpha v beta 3 (ανβ3) que l'Ang2-BD natif. L'invention concerne également des utilisations des variants Ang2-BD générés en tant qu'agents thérapeutiques contre le cancer et anti-angiogenèse.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2018173062A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2018173062A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2018173062A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAsDqL-w4FzoUlBu6bmYg40F5oTcSpF4iRaqP-Pix_g9Ja3VN7GI3FiQqEIpupsRgeJT7eEScghUAzUkXCfwUYHZ5TALgN7uGQECdgj-7VaPMbnXDY_V2rrUQ6hKtN7KPM03surfIYrm1q3et_UO2N189_6AlWzLR0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANGIOPOIETIN 2-BASED POLYPEPTIDE INHIBITORS AND METHODS OF USE THEREOF</title><source>esp@cenet</source><creator>PAPO, Niv ; SHLAMKOVICH, Tomer</creator><creatorcontrib>PAPO, Niv ; SHLAMKOVICH, Tomer</creatorcontrib><description>Described herein is the generation of inhibitory polypeptides based on the Ang2- binding domain (Ang2-BD), but having greater affinity for Tie2 and/or integrin alpha v beta 3 (ανβ3) than the native Ang2-BD. Uses of the generated Ang2-BD variants as cancer and anti- angiogenesis therapeutics are also described. L'invention concerne la génération de polypeptides inhibiteurs basés sur le domaine de liaison à Ang2 (Ang2-BD), mais ayant une affinité plus importante pour Tie2 et/ou l'intégrine alpha v beta 3 (ανβ3) que l'Ang2-BD natif. L'invention concerne également des utilisations des variants Ang2-BD générés en tant qu'agents thérapeutiques contre le cancer et anti-angiogenèse.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180927&amp;DB=EPODOC&amp;CC=WO&amp;NR=2018173062A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25573,76557</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180927&amp;DB=EPODOC&amp;CC=WO&amp;NR=2018173062A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAPO, Niv</creatorcontrib><creatorcontrib>SHLAMKOVICH, Tomer</creatorcontrib><title>ANGIOPOIETIN 2-BASED POLYPEPTIDE INHIBITORS AND METHODS OF USE THEREOF</title><description>Described herein is the generation of inhibitory polypeptides based on the Ang2- binding domain (Ang2-BD), but having greater affinity for Tie2 and/or integrin alpha v beta 3 (ανβ3) than the native Ang2-BD. Uses of the generated Ang2-BD variants as cancer and anti- angiogenesis therapeutics are also described. L'invention concerne la génération de polypeptides inhibiteurs basés sur le domaine de liaison à Ang2 (Ang2-BD), mais ayant une affinité plus importante pour Tie2 et/ou l'intégrine alpha v beta 3 (ανβ3) que l'Ang2-BD natif. L'invention concerne également des utilisations des variants Ang2-BD générés en tant qu'agents thérapeutiques contre le cancer et anti-angiogenèse.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAsDqL-w4FzoUlBu6bmYg40F5oTcSpF4iRaqP-Pix_g9Ja3VN7GI3FiQqEIpupsRgeJT7eEScghUAzUkXCfwUYHZ5TALgN7uGQECdgj-7VaPMbnXDY_V2rrUQ6hKtN7KPM03surfIYrm1q3et_UO2N189_6AlWzLR0</recordid><startdate>20180927</startdate><enddate>20180927</enddate><creator>PAPO, Niv</creator><creator>SHLAMKOVICH, Tomer</creator><scope>EVB</scope></search><sort><creationdate>20180927</creationdate><title>ANGIOPOIETIN 2-BASED POLYPEPTIDE INHIBITORS AND METHODS OF USE THEREOF</title><author>PAPO, Niv ; SHLAMKOVICH, Tomer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2018173062A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2018</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>PAPO, Niv</creatorcontrib><creatorcontrib>SHLAMKOVICH, Tomer</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAPO, Niv</au><au>SHLAMKOVICH, Tomer</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANGIOPOIETIN 2-BASED POLYPEPTIDE INHIBITORS AND METHODS OF USE THEREOF</title><date>2018-09-27</date><risdate>2018</risdate><abstract>Described herein is the generation of inhibitory polypeptides based on the Ang2- binding domain (Ang2-BD), but having greater affinity for Tie2 and/or integrin alpha v beta 3 (ανβ3) than the native Ang2-BD. Uses of the generated Ang2-BD variants as cancer and anti- angiogenesis therapeutics are also described. L'invention concerne la génération de polypeptides inhibiteurs basés sur le domaine de liaison à Ang2 (Ang2-BD), mais ayant une affinité plus importante pour Tie2 et/ou l'intégrine alpha v beta 3 (ανβ3) que l'Ang2-BD natif. L'invention concerne également des utilisations des variants Ang2-BD générés en tant qu'agents thérapeutiques contre le cancer et anti-angiogenèse.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2018173062A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title ANGIOPOIETIN 2-BASED POLYPEPTIDE INHIBITORS AND METHODS OF USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T23%3A31%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAPO,%20Niv&rft.date=2018-09-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2018173062A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true